E Xiang
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
-
- Chronic Kidney Disease and Diabetes
Papers in
-
- Plant Toxicity and Pharmacological Properties 4
- Epigenetics and DNA Methylation 2
- Surgery 6
- Tissue Engineering and Regenerative Medicine 3
- Bladder and Urothelial Cancer Treatments 2
- Co-authors
- Dongcheng Wu (5 shared papers)Wei Rao (4 shared papers)Bing Han (3 shared papers)Changyong Li (4 shared papers)Chengshu Tu (3 shared papers)Yaqi Zhang (3 shared papers)Quan Zhang (1 shared paper)Cheng Chang (1 shared paper)
- Journals
- Journal of Agricultural and Food Chemistry (1 paper)Current Stem Cell Research & Therapy (1 paper)Infection and Drug Resistance (1 paper)Medicine (1 paper)Toxicology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
E Xiang
17 papers receiving 449 citations
E Xiang's Hit Papers
Peers
Comparison fields: 5 of 84
- Genetics 139
- Nephrology 34
- Cancer Research 69
- Molecular Biology 205
- Clinical Biochemistry 17
Countries citing papers authored by E Xiang
This map shows the geographic impact of E Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Xiang more than expected).
Fields of papers citing papers by E Xiang
This network shows the impact of papers produced by E Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Xiang. The network helps show where E Xiang may publish in the future.
Co-authors
The 25 scholars most cited alongside E Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis Hit paper breakdown → | 2020 | 229 |
| 2 | 2019 | 57 | |
| 3 | 2021 | 33 | |
| 4 | 2020 | 26 | |
| 5 | 2022 | 20 | |
| 6 | 2021 | 17 | |
| 7 | 2020 | 13 | |
| 8 | 2023 | 11 | |
| 9 | 2019 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2018 | 8 | |
| 12 | 2018 | 7 | |
| 13 | 2022 | 5 | |
| 14 | 2023 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About E Xiang
E Xiang is a scholar working on Molecular Biology, Surgery, Genetics, Public Health, Environmental and Occupational Health and Pharmacology, having authored 19 papers that have together received 455 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (4 papers), Plant Toxicity and Pharmacological Properties (4 papers), Reproductive Health and Contraception (4 papers), Tissue Engineering and Regenerative Medicine (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Genetics (139 citations), Nephrology (34 citations), Cancer Research (69 citations), Molecular Biology (205 citations) and Clinical Biochemistry (17 citations). E Xiang has collaborated with scholars based in China and United States. Frequent co-authors include Dongcheng Wu, Wei Rao, Bing Han, Changyong Li, Chengshu Tu, Yaqi Zhang, Quan Zhang, Cheng Chang, Peizhan Chen and Changqiang Chen. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Current Stem Cell Research & Therapy, Infection and Drug Resistance, Medicine and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.